Clinical manifestation of congenital aniridia in Ukrainian children and adolescents

Authors

  • N. F. Bobrova SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»
  • T. V. Romanova SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»
  • G. M. Demnovetska SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»
  • T. A. Sorochynska SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»
  • K. S. Vdovichenko SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»
  • O. D. Dovhan SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»

DOI:

https://doi.org/10.31288/oftalmolzh202553643

Keywords:

congenital aniridia, aniridia-associated keratopathy, cararact, nystagmus

Abstract

Purpose: To investigate clinical manifestations of congenital aniridia (CA) in Ukrainian children and adolescents.
Material and Methods: Twenty four children and adolescents (47 eyes; group 1 of children under 11 years and group 2 of adolescents aged 11 to 18 years) and 5 adult parents (age, 38 to 48 years; group 3) of patients with CA were included in the study. Of these, 72.4% had familial aniridia and 27.6%, sporadic aniridia. The eye examination included gonioscopy, keratometry, ultrasound biometry, ultrasound examination of the anterior and posterior segments, phosphene assessment, and optical computed tomography.
Results: Most patients (75.0% in group 1, 86.7% in group 2, and 100% in group 3) had biomicroscopic evidence of complete aniridia. Aniridia-associated keratopathy (AAK) was found in all groups, with differences in clinical manifestations and severity of AAK between groups. Rates of stages A, B, C and D AAK were 0%, 12.5%, 0%, and 0%, respectively, for group 1, 0%, 40%, 20%, and 13.3%, respectively, for group 2, and 0%, 0%, 70%, and 30%, respectively, for group 3. Congenital cataract was found in 81.3% of eyes in group 1, and progressive cataract, in 86.7% of eyes in group 2. The rate of congenital glaucoma with corneal edema and buphthalmos was 12.5% in group 1. The rate of secondary glaucoma in groups 2 and 3 was 60%. Congenital foveal hypoplasia was observed in 93.75% and 93.3% of the eyes in children and adolescents, respectively. In groups 1, 2 and 3, visual acuity was more commonly ≤ 0.1, and 0.1-0.25 in 37.5%, 26.7%, and 20.0% of eyes, respectively.
Conclusion: CA is a rare bilateral panocular genetic disorder, which in 93.3-93.8% of our cases was associated with foveal hypoplasia, causing low vision. Clinical manifestations of CA (AAK, glaucoma, cataract, foveal hypoplasia, nystagmus, etc.) were found to increase in severity with age. Parents of aniridic children exhibited the worst state of the eye. Clinical manifestations of CA were more severe, with higher rates of complications, in eyes with familial CA, compared to eyes with sporadic CA.

Author Biographies

N. F. Bobrova, SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»

Nadiia F. Bobrova, Dr Sc (Med), Professor and Head, Pediatric Ophthalmology Department, State Institution "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine", Odesa, Ukraine

T. V. Romanova, SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»

Tetiana V. Romanova, Cand Sc (Med) and Researcher, State Institution "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine", Odesa, Ukraine

G. M. Demnovetska, SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»

Ganna M. Dembovetska, Cand Sc (Med) and Researcher, State Institution "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine", Odesa, Ukraine

T. A. Sorochynska, SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»

Tetiana A. Sorochynska, Cand Sc (Med) and Head,  Pediatric Eye Microsurgery Division, State Institution "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine", Odesa, Ukraine

K. S. Vdovichenko, SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»

Karina S. Vdovichenko, Junior Researcher, State Institution "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine", Odesa, Ukraine

O. D. Dovhan, SI «The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine»

Olga D. Dovhan, Junior Researcher, State Institution "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine", Odesa, Ukraine

References

Bobrova NF, Vit VV. [Atlas of congenital and hereditary diseases of the eye]. Odesa: Palmira; 2006. Russian.

Bobrova NF, Skrypnychenko ZM. [Toxic, congenital and secondary cataracts]. Odesa: Feniks; 2017. Russian.

Landsend ECS, Pedersen HR, Utheim OA, et al. Characteristics and Utility of Fundus Autofluorescence in Congenital Aniridia Using Scanning Laser Ophthalmoscopy. Invest Ophthalmol Vis Sci. 2019; 60 (13): 4120-4128. https://doi.org/10.1167/iovs.19-26994

Moosajee M, Hingorani M, Moore AT. PAX6-Related Aniridia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews((R)). University of Washington: Seattle, DC; 2018.

Hingorani M, Hanson I, van Heyningen V. Aniridia. Eur J Hum Genet. 2012; 20:1011-7. https://doi.org/10.1038/ejhg.2012.100

Landsend ECS, Lagali N, Utheim TP. Surv Ophthalmol. 2022 Mar-Apr;67(2):629-630. https://doi.org/10.1016/j.survophthal.2021.11.001

Kasmann-Kellner B, Seitz B. Aniridia syndrome: clinical findings, problematic courses and suggestions for optimization of care ("aniridia guide"). Ophthalmologe. 2014;111(12):1145-56.

Kit V, Cunha DL, Hagag AM, Moosajee M. Longitudinal genotype-phenotype analysis in 86 patients with PAX6-related aniridia. JCI Insight. 2021 Jul 22;6(14):e148406.https://doi.org/10.1172/jci.insight.148406

The UN Convention on the Rights of the Child as amended by General Assembly resolution 50/155 of 21 December 1995.

Mackman G, Brightbill FS, Optiz JM. Corneal changes in aniridia. Am J Ophthalmol. 1979;87(4):497-502.https://doi.org/10.1016/0002-9394(79)90238-1

Gronskov K, Olsen J, Sand A et al. Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. Hum Genet 2001;109:11-8. https://doi.org/10.1007/s004390100529

Eden U, Beijar C, Riise R et al. Aniridia among children and teenagers in Sweden and Norway. Acta Ophthalmol. 2008; 86: 730-4. https://doi.org/10.1111/j.1755-3768.2008.01310.x

Lee NY, Lee YE, Mok J, et al. Three cases with unusual ophthalmic phenotypes of congenital aniridia. Can J Ophthalmol. 2013; 48(4):340-342. https://doi.org/10.1016/j.jcjo.2013.02.009

Schanilec P, Biernacki R. Aniridia: a comparative overview. Am Orthopt J. 2014; 64:98-104. https://doi.org/10.3368/aoj.64.1.98

Netland PA, Scott ML, Boyle 4th JW, et al. Ocular and systemic findings in a survey of aniridia subjects. J AAPOS. 2011;15(6):562-566. https://doi.org/10.1016/j.jaapos.2011.07.009

Hingorani M, Williamson KA, Moore AT, et al. Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations. Invest Ophthalmol Vis Sci. 2009;50(6):2581-2590. https://doi.org/10.1167/iovs.08-2827

Lopez-Garcia J, Garcia-Lozano I, Rivas L, Martinez-Garchitorena J. Congenital aniridia keratopathy treatment. Arch Soc Esp Oftalmol. 2006;81:435. https://doi.org/10.4321/S0365-66912006000800004

Shiple D, Finklea B, Lauderdale J, Netland P. Keratopathy, cataract, and dry eye in a survey of aniridia subjects. Clin Ophthalmol. 2015; 9: 291-5. https://doi.org/10.2147/OPTH.S74648

Park SH, Park YG, Lee MY, Kim MS. Clinical features of Korean patients with congenital aniridia. Korean J Ophthalmol. 2010;24(5):291-296. https://doi.org/10.3341/kjo.2010.24.5.291

Eden U, Lagali N, Dellby A, et al. Cataract development in Norwegian patients with congenital aniridia. Acta Ophthalmol. 2014;92(2):165-e167. https://doi.org/10.1111/aos.12225

Singh B, Mohamed A, Chaurasia S, et al. Clinical manifestations of congenital aniridia. J Pediatr Ophthalmol Strabismus. 2014; 51(1):59-62. https://doi.org/10.3928/01913913-20131223-01

Baulmann DС, Oplmann A, Flugel-Koch C, et al. PAX6 heterozygous eyes show defects in chamber angle differentiation that are associated with a wide spectrum of other anterior eye segment abnormalities. Mech Dev. 2002;118:3-17. https://doi.org/10.1016/S0925-4773(02)00260-5

Thomas MG, Kumar A, Mohammad S et al. Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity. Ophthalmology. 2011;118(8):1653-1660.https://doi.org/10.1016/j.ophtha.2011.01.028

Idrissi SBA, Moutei H, Bennis A, Chraibi F, Abdellaoui M, Andaloussi IB. Shedding light on congenital aniridia: an in-depth study of two cases. JFO Open Ophthalmology. 2024; 8(6):100146.https://doi.org/10.1016/j.jfop.2024.100146

Hall J, Corton M et al. Comprehensive Analysis of Congenital Aniridia and Differential Diagnoses: Genetic Insights and Clinical Manifestations. Ophthalmol Ther. 2025 May;14(5):835-856.https://doi.org/10.1007/s40123-025-01122-1

Published

2025-10-30

How to Cite

[1]
Bobrova, N.F. et al. 2025. Clinical manifestation of congenital aniridia in Ukrainian children and adolescents. Journal of Ophthalmology (Ukraine). 5 (Oct. 2025), 36–43. DOI:https://doi.org/10.31288/oftalmolzh202553643.

Issue

Section

Clinical Ophthalmology

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.